A non-surgical pharmacological approach to control cellular vitality and functionality during ischemic and/or reperfusion-induced phases of strokes remains extremely important. The synthesis of 2-ethyl-6-methyl-3-hydroxypyridinium gammalactone-2,3-dehydro-L-gulonate (3-EA) was performed using a topochemical reaction. The cell-protective effects of 3-EA were studied on a model of glutamate excitotoxicity (GluTox) and glucose-oxygen deprivation (OGD) in a culture of NMRI mice cortical cells. Ca2+ dynamics was studied using fluorescent bioimaging and a Fura-2 probe, cell viability was assessed using cytochemical staining with propidium iodide, and gene expression was assessed by a real-time polymerase chain reaction. The compound anti-ischemic efficacy in vivo was evaluated on a model of irreversible middle cerebral artery (MCA) occlusion in Sprague-Dawley male rats. Brain morphological changes and antioxidant capacity were assessed one week after the pathology onset. The severity of neurological disorder was evaluated dynamically. 3-EA suppressed cortical cell death in a dose-dependent manner under the excitotoxic effect of glutamate and ischemia/reoxygenation. Pre-incubation of cerebral cortex cells with 10–100 µM 3-EA led to significant stagnation in Ca2+ concentration in a cytosol ([Ca2+]i) of neurons and astrocytes suffering GluTox and OGD. Decreasing intracellular Ca2+ and establishing a lower [Ca2+]i baseline inhibited necrotic cell death in an acute experiment. The mechanism of 3-EA cytoprotective action involved changes in the baseline and ischemia/reoxygenation-induced expression of genes encoding anti-apoptotic proteins and proteins of the oxidative status; this led to inhibition of the late irreversible stages of apoptosis. Incubation of brain cortex cells with 3-EA induced an overexpression of the anti-apoptotic genes BCL-2, STAT3, and SOCS3, whereas the expression of genes regulating necrosis and inflammation (TRAIL, MLKL, Cas-1, Cas-3, IL-1β and TNFa) were suppressed. 3-EA 18.0 mg/kg intravenous daily administration for 7 days following MCA occlusion preserved rats’ cortex neuron population, decreased the severity of neurological deficit, and spared antioxidant capacity of damaged tissues. 3-EA demonstrated proven short-term anti-ischemic activity in vivo and in vitro, which can be associated with antioxidant activity and the ability to target necrotic and apoptotic death. The compound may be considered a potential neuroprotective molecule for further pre-clinical investigation.
1 December 2022 in Bulletin of the Russian Academy of Sciences: Physics
Intraoperative monitoring of cerebral blood flow provides an important information required for clinicians to select optimal tactics during the neurosurger
4 April 2025 in Burdenko's Journal of Neurosurgery
Background. High-risk cerebral AVMs (Spetzler-Martin grade IV—V) are characterized by higher cumulative risk of hemorrhage during life, as well as higher mortality and disability rates in case of rupture compared to low-risk AVMs. Nevertheless, there are currently no clear indications for surgical intervention for high-risk AVMs, and most patients with this disease are followed-up. However, available data on less favorable course of high-risk AVMs requires active surgical tactics to reduce long-term disability and mortality. Currently, the following strategies are preferable for high-risk AVMs: combination of preoperative embolization with microsurgical resection and combination of partial endovascular embolization with subsequent radiosurgery. Objective. To analyze the most common treatment combinations for high-risk AVMs regarding resection quality, functional outcomes and complications. Material and methods. The study was carried out in accordance with international recommendations for systematic reviews and meta-analyses (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). Searching was conducted in the Pubmed/Medline and eLibrary databases using the keywords «High grade», «Arteriovenous Malformations», «Management», «IV—V» and «AVM» for English-language search engines, “high-grade arteriovenous malformations.” for Russian-language systems. Available full-text English- and Russian-language articles were selected between 1981 and 2024. Results. Among 371 articles, 6 studies met the inclusion criteria. There were 478 patients who underwent two most common strategies for combined treatment of high-risk AVMs. Conclusion. At present, there is no consensus on the advantage of certain combined method. There are data on less favorable course of high-grade AVMs and unsatisfactory outcomes after monomodal treatment. Thus, combined methods may be valuable for such AVMs.
30 March 2022 in Bulletin "Biomedicine and sociology"
The anticonvulsant activity of 2-aminoethanesulfonic derivatives - magnesium bis-acetamino-2-aminoethanesulfonate (LHT-317) and zinc cyclo-bis-acetamino-2-aminoethanesulphonate (LHT-318) derivatives was studied in the model of pilacorpine epileptogenesis. The studies were performed on 30 white laboratory rats, in which epilepsy was modeled by intraperitoneal administration of pilocarpine hydrochloride at a dose of 320 mg/kg. Within 4 weeks after the formation of epilepsy rats were got intragastrically LHT-31, LHT-318 and Carbamazepine at doses of 2.5% and 5% of the LD50 determined for rats with this route of administration. Carbamazepine was used as the reference drug. The frequency, duration and severity of seizures were assessed using the Krushinsky scale. Morphological studies of the brain in the hippocampus and dentate sulcus were profiled by Nissl staining using 0.4% cresyl violet. The results were evaluated using an Olympus Bx50 digital microscope, x400 magnification over an area of 1000 µm2. The zinc salt of 2-aminoethanesulfonic acid LHT-318 exhibited anticonvulsant properties: it reduced the severity of acute convulsive paroxysm, prevented the formation of spontaneous convulsive activity, and was comparable in activity to the reference drug carbamazepine. LHT-317 did not demonstrate antiepileptic activity in this model. Compounds LHT-317 and LHT-318 at course administration prevented the depth of morphological changes characteristic of pilocarpine epileptogenesis, while it should be emphasized that complete prevention of morphological disorders is not observed in any case. Thus, based on the study, we can conclude that the zinc cyclic salt of 2-aminoethanesulfonic acid can be considered as a potential drug for the treatment of epilepsy.